Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 7, 2012, Pages 1593-1605

  Selenius, Markus ^a   Hedman, Mattias ^b   Brodin, David ^c   Gandin, Valentina ^d   Rigobello, Maria Pia ^d   Flygare, Jenny ^a   Marzano, Christine ^d   Bindoli, Alberto ^d   Brodin, Ola ^b   Björnstedt, Mikael ^a   Fernandes, Aristi P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Ionizing radiation; Lung cancer; Radiation resistance; Radiosensitizer; Thioredoxin reductase

Indexed keywords

GOLD DERIVATIVE; PHOSPHINE; PHOSPHINE DERIVATIVE; SMALL INTERFERING RNA; THIOREDOXIN REDUCTASE;

ARTICLE; CELL CYCLE; CELL LINE; DRUG ANTAGONISM; GENETICS; HUMAN; IONIZING RADIATION; LUNG TUMOR; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; RADIATION DOSE; RADIATION EXPOSURE; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CYCLE; CELL LINE; GOLD COMPOUNDS; HUMANS; LUNG NEOPLASMS; OXIDATION-REDUCTION; PHOSPHINES; RADIATION TOLERANCE; RADIATION, IONIZING; RNA, SMALL INTERFERING; THIOREDOXIN-DISULFIDE REDUCTASE; UP-REGULATION;

EID: 84863100036     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01469.x     Document Type: Article

References (43)

1. Powell SN, Abraham EH. The biology of radioresistance: similarities, differences and interactions with drug resistance. Cytotechnology. 1993; 12: 325-45.
2. Wardman P. Chemical radiosensitizers for use in radiotherapy. Clin Oncol (R Coll Radiol). 2007; 19: 397-417.
3. Demizu Y, Sasaki R, Trachootham D, et al. Alterations of cellular redox state during NNK-induced malignant transformation and resistance to radiation. Antioxid Redox Signal. 2008; 10: 951-61.
4. Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009; 458: 780-3.
5. Lee HC, Kim DW, Jung KY, et al. Increased expression of antioxidant enzymes in radioresistant variant from U251 human glioblastoma cell line. Int J Mol Med. 2004; 13: 883-7.
6. Mirkovic N, Voehringer DW, Story MD, et al. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols. Oncogene. 1997; 15: 1461-70.
7. Sun J, Chen Y, Li M, et al. Role of antioxidant enzymes on ionizing radiation resistance. Free Radic Biol Med. 1998; 24: 586-93.
8. Biaglow JE, Ayene IS, Koch CJ, et al. Radiation response of cells during altered protein thiol redox. Radiat Res. 2003; 159: 484-94.
9. Husbeck B, Peehl DM, Knox SJ. Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing. Free Radic Biol Med. 2005; 38: 50-7.
10. Karimpour S, Lou J, Lin LL, et al. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene. 2002; 21: 6317-27.
11. Wei SJ, Botero A, Hirota K, et al. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res. 2000; 60: 6688-95.
12. Arner ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. 2000; 267: 6102-9.
13. Gromer S, Urig S, Becker K. The thioredoxin system-from science to clinic. Med Res Rev. 2004; 24: 40-89.
14. Holmgren A. Thioredoxin. Annu Rev Biochem. 1985; 54: 237-71.
15. Bragadin M, Scutari G, Folda A, et al. Effect of metal complexes on thioredoxin reductase and the regulation of mitochondrial permeability conditions. Ann N Y Acad Sci. 2004; 1030: 348-54.
16. Omata Y, Folan M, Shaw M, et al. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Toxicol In Vitro. 2006; 20: 882-90.
17. Rigobello M, Messori L, Marcon G, et al. Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions. J Inorg Biochem. 2004; 98: 1634-41.
18. Rigobello MP, Folda A, Baldoin MC, et al. Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase. Free Radic Res. 2005; 39: 687-95.
19. Rigobello MP, Scutari G, Folda A, et al. Mitochondrial thioredoxin reductase inhibition by gold(I) compounds and concurrent stimulation of permeability transition and release of cytochrome c. Biochem Pharmacol. 2004; 67: 689-96.
20. Marzano C, Gandin V, Folda A, et al. Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells. Free Radic Biol Med. 2007; 42: 872-81.
21. Chendil D, Ranga RS, Meigooni D, et al. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene. 2004; 23: 1599-607.
22. Srinivasan M, Rajendra Prasad N, Menon VP. Protective effect of curcumin on gamma-radiation induced DNA damage and lipid peroxidation in cultured human lymphocytes. Mutat Res. 2006; 611: 96-103.
23. Gandin V, Fernandes AP, Rigobello MP, et al. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Biochem Pharmacol. 79: 90-101.
24. Fishel ML, Kelley MR. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med. 2007; 28: 375-95.
25. Hirota K, Matsui M, Iwata S, et al. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA. 1997; 94: 3633-8.
26. 2O), and (mu-S)[Au(PEt3)]2. Inorg Chem. 1990; 29: 480-4.
27. Brodin O, Lennartsson L, Nilsson S. Single-dose and fractionated irradiation of four human lung cancer cell lines in vitro. Acta Oncol. 1991; 30: 967-74.
28. Brodin O, Arnberg H, Bergh J, et al. Increased radioresistance of an in vitro transformed human small cell lung cancer cell line. Lung Cancer. 1995; 12: 183-98.
29. Johansson L, Nilsson K, Carlsson J, et al. Radiation effects on cultured human lymphoid cells. Analysis using the growth extrapolation method. Acta Radiol Oncol. 1981; 20: 51-9.
30. Holmgren A, Bjornstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol. 1995; 252: 199-208.
31. Rundlof AK, Fernandes AP, Selenius M, et al. Quantification of alternative mRNA species and identification of thioredoxin reductase 1 isoforms in human tumour cells. Differentiation. 2007; 75: 123-32.
32. Arlandson M, Decker T, Roongta VA, et al. Eosinophil peroxidase oxidation of thiocyanate. Characterization of major reaction products and a potential sulfhydryl-targeted cytotoxicity system. J Biol Chem. 2001; 276: 215-24.
33. Thomas E. The Lactoperoxidase System, Chemsistry and Biological Significance. New York: Marcel Dekker; 1985.
34. Mikkelsen RB, Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene. 2003; 22: 5734-54.
35. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004; 59: 928-42.
36. Sirzen F, Heiden T, Nilsson A, et al. Characterisation of the G1/S cell cycle checkpoint defect in lung carcinoma cells with different intrinsic radiosensitivities. Anticancer Res. 1997; 17: 3381-6.
37. Yoo MH, Xu XM, Carlson BA, et al. Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication. PLoS One. 2007; 2: e1112.
38. Gan L, Yang XL, Liu Q, et al. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells. J Cell Biochem. 2005; 96: 653-64.
39. Powell S, McMillan TJ. DNA damage and repair following treatment with ionizing radiation. Radiother Oncol. 1990; 19: 95-108.
40. Ross GM. Induction of cell death by radiotherapy. Endocr Relat Cancer. 1999; 6: 41-4.
41. Willers H, Dahm-Daphi J, Powell SN. Repair of radiation damage to DNA. Br J Cancer. 2004; 90: 1297-301.
42. Bertini R, Howard OM, Dong HF, et al. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med. 1999; 189: 1783-9.
43. Pekkari K, Avila-Carino J, Gurunath R, et al. Truncated thioredoxin (Trx80) exerts unique mitogenic cytokine effects via a mechanism independent of thiol oxido-reductase activity. FEBS Lett. 2003; 539: 143-8.